The effectiveness of dapagliflozin and lixisenatide in managing Type 2 diabetes: a real-world observational study

被引：0
|
作者：
Duffy, A. [1 ]
Smith, C. [1 ]
Harrow, C. [1 ]
McGowan, N. [1 ]
McIntyre, M. [1 ]
So, B. [1 ]
Jones, C. [2 ]
Gonzalez, N. [1 ]
机构：
[1] Royal Alexandra Hosp, Dept Endocrinol, Paisley, Renfrew, Scotland
[2] Inverclyde Royal Hosp, Dept Endocrinol, Greenock, Scotland
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P437
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [31] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Tanaka, Kenichi
    Okada, Yosuke
    Tokutsu, Akemi
    Tanaka, Yoshiya
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] REAL-WORLD EFFECTIVENESS OF IGLARLIXI THERAPY IN OUTPATIENTS WITH TYPE 2 DIABETES: THE SOLO RETROSPECTIVE COHORT STUDY
    Antsiferov, M.
    Demidov, N.
    Balberova, M.
    Safronova, T.
    Mishra, O.
    Magomedova, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A177 - A178
  • [33] Multidisciplinary stakeholder engagement in a type 2 diabetes comparative effectiveness study utilizing real-world data
    Golembiewski, Elizabeth H.
    Mickelson, Mindy M.
    Brito, Juan P.
    Montori, Victor M.
    Mccoy, Rozalina G.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 8 (01)
  • [34] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Kenichi Tanaka
    Yosuke Okada
    Akemi Tokutsu
    Yoshiya Tanaka
    Scientific Reports, 12
  • [35] Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study
    Guo, Lixin
    Li, Li
    Yu, Qiurong
    Wang, Na
    Chen, Jun
    Xi, Yue
    Wang, Huan
    Wang, Yihua
    Xu, Jiawei
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3578 - 3588
  • [36] A Real-World, Multicentre, Retrospective, Observational Study to Evaluate the Effectiveness and Safety of Lobeglitazone in Type 2 Diabetes Mellitus Patients in India (LODIAB INDIA)
    Barkate, Hanmant V.
    Chitnis, Kruttika R.
    Petare, Anup U.
    Choudhari, Sanjay Y.
    Bhushan, Sumit
    Patil, Saiprasad
    DIABETES, 2024, 73
  • [37] A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Drugs Added to Metformin in Patients with Type 2 Diabetes
    Huang, Huan
    Bell, Kelly F.
    Gani, Ray
    Tugwell, Cathy W.
    Eudicone, James M.
    Krukas-Hampel, Michelle R.
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : S132 - S137
  • [38] Real-world safety of dapagliflozin in elderly patients with type 2 diabetes in China: post-hoc analysis of the DONATE study
    Guo, L.
    Wang, J.
    Li, L.
    Yuan, L.
    Chen, S.
    Wang, H.
    Li, T.
    Qi, L.
    Yang, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S278 - S279
  • [39] Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
    Cho, Yun Kyung
    Lee, Jiwoo
    Kim, Hwi Seung
    Park, Joong-Yeol
    Jung, Chang Hee
    Lee, Woo Je
    DIABETES THERAPY, 2020, 11 (09) : 2029 - 2039
  • [40] Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
    Yun Kyung Cho
    Jiwoo Lee
    Hwi Seung Kim
    Joong-Yeol Park
    Chang Hee Jung
    Woo Je Lee
    Diabetes Therapy, 2020, 11 : 2029 - 2039
12345